Stockscreener 앱 받기
8.50
2.91%
0.24
전일 마감가:
$8.26
열려 있는:
$8.36
하루 거래량:
188.39K
Relative Volume:
0.16
시가총액:
$569.37M
수익:
-
순이익/손실:
$-103.21M
주가수익비율:
-1.8478
EPS:
-4.6001
순현금흐름:
$-26.70M
1주 성능:
-5.87%
1개월 성능:
+5.33%
6개월 성능:
+123.10%
1년 성능:
+9.54%
1일 변동 폭
$8.30
$9.04
1주일 범위
$8.17
$9.10
52주 변동 폭
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
명칭
Engene Holdings Inc
전화
(514) 332-4888
주소
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
ENGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
8.50 | 553.29M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | 개시 | Piper Sandler | Overweight |
| 2025-02-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2024-11-27 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-08-28 | 개시 | Oppenheimer | Outperform |
| 2024-04-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-03-28 | 개시 | UBS | Buy |
| 2024-03-08 | 개시 | Morgan Stanley | Overweight |
| 2024-02-20 | 개시 | Leerink Partners | Outperform |
모두보기
Engene Holdings Inc 주식(ENGN)의 최신 뉴스
enGene Holdings Inc Stock Analysis and ForecastValue Traps to Avoid & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Citizens reiterates Market Outperform rating on Engene stock with $21 target - Investing.com Canada
enGene (NASDAQ:ENGN) Shares Gap Up – Should You Buy? - Defense World
enGene (NASDAQ:ENGN) Shares Gap UpStill a Buy? - MarketBeat
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
While Institutions Invested in EnGene Holdings Inc. (NASDAQ:ENGN) Benefited From Last Week's 21% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Agios Pharma (AGIO) - The Globe and Mail
HC Wainwright Forecasts enGene's Q1 Earnings (NASDAQ:ENGN) - MarketBeat
enGene (NASDAQ:ENGN) Sees Large Volume IncreaseHere's Why - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Trading Up 4.6%What's Next? - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages - Investing.com Nigeria
enGene Reports Full Year 2025 Financial Results and Provides Business Update - BioSpace
enGene completes enrollment in bladder cancer treatment trial - Investing.com India
enGene completes enrollment in bladder cancer treatment trial By Investing.com - Investing.com Nigeria
EnGene Fiscal 2025 Loss Widens - marketscreener.com
enGene (NASDAQ:ENGN) Announces Earnings Results - MarketBeat
enGene Holdings Inc. SEC 10-K Report - TradingView — Track All Markets
EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2025 - marketscreener.com
enGene announces proposed public offering - MSN
Will enGene Holdings Inc. stock rally after Fed decisionsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Is enGene Holdings Inc. Equity Warrant stock a top pick in earnings season2025 Volume Leaders & Verified Swing Trading Watchlists - Улправда
Weekly Recap: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Catalysts & Expert Curated Trade Setups - Улправда
Will enGene Holdings Inc. stock benefit from AI adoption2025 Market WrapUp & Long Hold Capital Preservation Tips - bolumsonucanavari.com
Valuation Update: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a good choice for value investorsWeekly Profit Recap & Fast Moving Trade Plans - Улправда
How enGene Holdings Inc. stock performs in stagflationJuly 2025 Decliners & AI Driven Price Forecasts - Улправда
How sustainable is enGene Holdings Inc. Equity Warrant stock dividend payout2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunityJuly 2025 Selloffs & Scalable Portfolio Growth Ideas - DonanımHaber
How enGene Holdings Inc. Equity Warrant stock performs in weak economyOil Prices & Weekly Setup with ROI Potential - DonanımHaber
How enGene Holdings Inc. stock performs in high volatility marketsPortfolio Update Report & Daily Volume Surge Signals - DonanımHaber
Insider Trends: Is enGene Holdings Inc. Equity Warrant stock a good choice for value investors2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Quarterly Risk: Is enGene Holdings Inc. Equity Warrant stock a top pick in earnings season2025 Earnings Impact & Weekly Return Optimization Alerts - Улправда
enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates - MSN
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
enGene (NASDAQ:ENGN) Shares Gap DownShould You Sell? - MarketBeat
enGene Holdings Inc trading resumes - MSN
enGene Holdings Amends CEO Severance Package - MSN
enGene (NASDAQ:ENGN) Stock Price Up 8.2%Time to Buy? - MarketBeat
enGene (ENGN) Projected to Post Earnings on Thursday - MarketBeat
Holdings of enGene Holdings Inc (ENGN) are aligned with the stars - setenews.com
EnGene Holdings Inc (ENGN) surging after positive phase 2 LEGEND trial - MSN
Market Recap: Can enGene Holdings Inc Equity Warrant stock attract ESG capital inflowsQuarterly Earnings Summary & Smart Money Movement Alerts - moha.gov.vn
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program - TipRanks
enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial - Finviz
Engene Holdings Inc (ENGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):